Monday, December 26, 2011

Dexall


Generic Name: dexbrompheniramine, dextromethorphan, and phenylephrine (dex brom feh NEER a meen, dex tro meh THOR fan, and feh nill EFF rin)

Brand Names: Dexall, Tussall, Tussall-ER, Y-Cof DM


What is Dexall (dexbrompheniramine, dextromethorphan, and phenylephrine)?

Dexbrompheniramine is an antihistamine that reduces the effects of the natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose.


Dextromethorphan is a cough suppressant. It affects the signals in the brain that trigger cough reflex.


Phenylephrine is a decongestant that shrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose).


The combination of dexbrompheniramine, dextromethorphan, and phenylephrine is used to treat runny or stuffy nose, sneezing, itching, watery eyes, cough, and sinus congestion caused by allergies, the common cold, or the flu.


This medicine will not treat a cough that is caused by smoking, asthma, or emphysema.

Dexbrompheniramine, dextromethorphan, and phenylephrine may also be used for purposes not listed in this medication guide.


What is the most important information I should know about Dexall (dexbrompheniramine, dextromethorphan, and phenylephrine)?


Do not give this medication to a child younger than 4 years old. Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children. You should not use this medication if you have severe constipation, a blockage in your stomach or intestines, or if you are unable to urinate. Do not use cough or cold medicine if you have untreated or uncontrolled diseases such as glaucoma, asthma or COPD, high blood pressure, heart disease, coronary artery disease, or overactive thyroid. Do not use cough or cold medicine if you have used an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

What should I discuss with my healthcare provider before taking Dexall (dexbrompheniramine, dextromethorphan, and phenylephrine)?


Do not use cough or cold medicine if you have used an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects. You should not use this medication if you have severe constipation, a blockage in your stomach or intestines, or if you are unable to urinate. Do not use cough or cold medicine if you have untreated or uncontrolled diseases such as glaucoma, asthma or COPD, high blood pressure, heart disease, coronary artery disease, or overactive thyroid.

Ask a doctor or pharmacist if it is safe for you to take this medication if you have:



  • a blockage in your digestive tract (stomach or intestines), a colostomy or ileostomy;




  • diabetes;




  • liver or kidney disease;




  • epilepsy or other seizure disorder;




  • cough with mucus, or cough caused by emphysema or chronic bronchitis;




  • enlarged prostate or urination problems;




  • low blood pressure;




  • pheochromocytoma (an adrenal gland tumor); or




  • if you take potassium (Cytra, Epiklor, K-Lyte, K-Phos, Kaon, Klor-Con, Polycitra, Urocit-K).




FDA pregnancy category C. It is not known whether this medication will harm an unborn baby. Do not use cough or cold medicine without medical advice if you are pregnant. This medicine may pass into breast milk and may harm a nursing baby. Antihistamines and decongestants may also slow breast milk production. Do not use cough or cold medicine without medical advice if you are breast-feeding a baby.

How should I take Dexall (dexbrompheniramine, dextromethorphan, and phenylephrine)?


Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. Cough or cold medicine is usually taken only for a short time until your symptoms clear up.


Do not give this medication to a child younger than 4 years old. Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children.

Do not take for longer than 7 days in a row. Talk with your doctor if your symptoms do not improve after 7 days of treatment, or if you have a fever with a headache or skin rash.


Measure liquid medicine with a special dose-measuring spoon or medicine cup, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.


Do not crush, chew, break, or open an extended-release tablet. Swallow it whole. Breaking the pill may cause too much of the drug to be released at one time. If you need surgery or medical tests, tell the surgeon or doctor ahead of time if you have taken a cough or cold medicine within the past few days. Store at room temperature away from moisture and heat. Do not freeze.

What happens if I miss a dose?


Since cough or cold medicine is taken when needed, you may not be on a dosing schedule. If you are taking the medication regularly, take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

Overdose symptoms may include severe forms of some of the side effects listed in this medication guide.


What should I avoid while taking Dexall (dexbrompheniramine, dextromethorphan, and phenylephrine)?


This medicine may cause blurred vision and may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert and able to see clearly. Drinking alcohol can increase certain side effects of this medication. Ask a doctor or pharmacist before using any other cold, allergy, cough, or sleep medicine. Antihistamines, cough suppressants, and decongestants are contained in many combination medicines. Taking certain products together can cause you to get too much of a certain drug. Check the label to see if a medicine contains an antihistamine, cough suppressant, or decongestant.

Avoid taking this medication if you also take diet pills, caffeine pills, or other stimulants (such as ADHD medications). Taking a stimulant together with a decongestant can increase your risk of unpleasant side effects.


Avoid becoming overheated or dehydrated during exercise and in hot weather. This medication can decrease sweating and you may be more prone to heat stroke.

Dexall (dexbrompheniramine, dextromethorphan, and phenylephrine) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. Stop using this medicine and call your doctor at once if you have a serious side effect such as:

  • fast, slow, or uneven heart rate;




  • severe headache, mood changes, hallucinations;




  • severe dizziness or anxiety, feeling like you might pass out;




  • tremor, seizure (convulsions);




  • easy bruising or bleeding, unusual weakness;




  • fever;




  • urinating less than usual or not at all;




  • feeling short of breath; or




  • dangerously high blood pressure (severe headache, blurred vision, buzzing in your ears, anxiety, confusion, chest pain, uneven heartbeats, seizure).



Less serious side effects may include:



  • mild headache;




  • mild dizziness, drowsiness;




  • dry mouth, nose, or throat;




  • nausea, diarrhea, constipation, upset stomach;




  • feeling nervous, restless, or irritable;




  • blurred vision; or




  • sleep problems (insomnia).



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Dexall (dexbrompheniramine, dextromethorphan, and phenylephrine)?


Ask a doctor or pharmacist before using this medicine if you regularly use other medicines that make you sleepy (such as narcotic pain medication, sedatives, sleeping pills, muscle relaxers, and medicine for seizures, depression or anxiety). They can add to sleepiness caused by dexbrompheniramine or dextromethorphan.


Ask a doctor or pharmacist if it is safe for you to take this medication if you are also using any of the following drugs:



  • atropine (Atreza, Sal-Tropine);




  • benztropine (Cogentin);




  • topiramate (Topamax);




  • zonisamide (Zonegran);




  • an antidepressant such as citalopram (Celexa), duloxetine (Cymbalta), escitalopram (Lexapro), fluoxetine (Prozac, Sarafem, Symbyax), paroxetine (Paxil, Pexeva), sertraline (Zoloft), venlafaxine (Effexor), and others;




  • anti-nausea medications such as belladonna (Donnatal), dimenhydrinate (Dramamine), droperidol (Inapsine), methscopolamine (Pamine), or scopolamine (Transderm Scop);




  • bladder or urinary medications such as darifenacin (Enablex), flavoxate (Urispas), oxybutynin (Ditropan, Oxytrol), solifenacin (Vesicare), tolterodine (Detrol), or Urogesic Blue;




  • bronchodilators such as ipratropium (Atrovent) or tiotropium (Spiriva);




  • irritable bowel medications such as dicyclomine (Bentyl), hyoscyamine (Hyomax), or propantheline (Pro Banthine); or




  • ulcer medicine such as glycopyrrolate (Robinul) or mepenzolate (Cantil).



This list is not complete and other drugs may interact with dexbrompheniramine, dextromethorphan, and phenylephrine. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Dexall resources


  • Dexall Use in Pregnancy & Breastfeeding
  • Dexall Drug Interactions
  • Dexall Support Group
  • 0 Reviews for Dexall - Add your own review/rating


  • Y-Cof DM Sustained-Release Tablets MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Dexall with other medications


  • Cough and Nasal Congestion


Where can I get more information?


  • Your pharmacist can provide more information about dexbrompheniramine, dextromethorphan, and phenylephrine.


Saturday, December 24, 2011

Taltirelin




Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0103300-74-9

Chemical Formula

C17-H23-N7-O5

Molecular Weight

405

Therapeutic Category

Analogue of protirelin (thyrotropin releasing hormone, TRH)

Chemical Names

(S)-N-(1-methyl-4,5-dihydroorotyl)-L-histidyl-L-prolinamide

(-)-N-[[(S)-hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl]carbonyl]-L-histidyl-L-prolinamide (WHO)

N-{[(4S)-1-methyl-2,6-dioxohexahydropyrimidin-4-yl]carbonyl}-L-histidyl-L-prolinamide (IUPAC)

Foreign Names

  • Taltirelinum (Latin)
  • Taltirelin (German)
  • Taltiréline (French)
  • Taltirelina (Spanish)

Generic Names

  • UNII-DOZ62MV6A5 (IS)
  • Taltirelin Hydrate (OS: JAN)
  • TA-0910 (IS)
  • Taltirelin tetrahydrate (IS)

Brand Name

  • Ceredist
    Tanabe Mitsubishi, Japan

International Drug Name Search

Glossary

IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, December 22, 2011

Risperin




Risperin may be available in the countries listed below.


Ingredient matches for Risperin



Risperidone

Risperidone is reported as an ingredient of Risperin in the following countries:


  • Argentina

International Drug Name Search

Monday, December 19, 2011

Amoxicillina Pliva




Amoxicillina Pliva may be available in the countries listed below.


Ingredient matches for Amoxicillina Pliva



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicillina Pliva in the following countries:


  • Italy

International Drug Name Search

Deep Vein Thrombosis, First Event Medications


Drugs associated with Deep Vein Thrombosis, First Event

The following drugs and medications are in some way related to, or used in the treatment of Deep Vein Thrombosis, First Event. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Deep Vein Thrombosis, First Event





Drug List:

Monday, December 12, 2011

Benzo-Jel Banana



benzocaine

Dosage Form: gel, dentifrice
BENZO-JEL™

INGREDIENTS


Each gram of Benzo-Jel™ 20% benzocaine gel contains between 180-220 mg benzocaine U.S.P., in a water soluble base of PEG 3350 USP, PEG 400 USP, flavor, Sodium Saccharin USP, and FD&C Yellow #5, and FD&C Red #40.


CAUTION: Contains FD&C Yellow #5 (tartrazine) which may cause an allergic response.



USUAL DOSAGE


For oral mucosal use only as directed by a dentist.



Warning



Keep out of the reach of children.



Store at controlled room temperature 59°-86°F (15°-30°C).



Do not use on people with known allergies to benzocaine and PABA compounds.



CAUTION


Federal law (USA) prohibits dispensing without prescription.



Distributed By:

HENRY SCHEIN INC.

Melville, NY 11747



PRINCIPAL DISPLAY PANEL - 29.6 mL Bottle Label


HENRY SCHEIN®


BENZO-JEL™

TOPICAL ANESTHETIC GEL


Banana Flavor


20% Benzocaine

FOR PROFESSIONAL USE ONLY

1 FL. OZ. (29.6 mL)










BENZO-JEL   BANANA
benzocaine  gel, dentifrice










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)0404-0731
Route of AdministrationDENTALDEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Benzocaine (Benzocaine)Benzocaine220 mg  in 1 g





Inactive Ingredients
Ingredient NameStrength
No Inactive Ingredients Found


















Product Characteristics
Color    Score    
ShapeSize
FlavorBANANAImprint Code
Contains      










Packaging
#NDCPackage DescriptionMultilevel Packaging
10404-0731-0134 g In 1 BOTTLENone










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
UNAPPROVED DRUG OTHER02/19/1963


Labeler - Henry Schein, Inc. (012430880)

Registrant - DSHealthcare (056296981)









Establishment
NameAddressID/FEIOperations
DENTSPLY Caulk083235549MANUFACTURE
Revised: 07/2010Henry Schein, Inc.




More Benzo-Jel Banana resources


  • Benzo-Jel Banana Side Effects (in more detail)
  • Benzo-Jel Banana Use in Pregnancy & Breastfeeding
  • Benzo-Jel Banana Support Group
  • 0 Reviews for Benzo-Jel Banana - Add your own review/rating


Compare Benzo-Jel Banana with other medications


  • Anal Itching
  • Anesthesia
  • Aphthous Ulcer
  • Burns, External
  • Cold Sores
  • Hemorrhoids
  • Oral and Dental Conditions
  • Pain
  • Pruritus
  • Sunburn
  • Tonsillitis/Pharyngitis

Saturday, December 3, 2011

Bristacycline




Ingredient matches for Bristacycline



Tetracycline

Tetracycline hydrochloride (a derivative of Tetracycline) is reported as an ingredient of Bristacycline in the following countries:


  • United States

International Drug Name Search

Friday, December 2, 2011

Graminol




Graminol may be available in the countries listed below.


Ingredient matches for Graminol



Dimenhydrinate

Dimenhydrinate is reported as an ingredient of Graminol in the following countries:


  • Peru

International Drug Name Search

Thursday, December 1, 2011

Padoparine




Padoparine may be available in the countries listed below.


Ingredient matches for Padoparine



Bromocriptine

Bromocriptine mesilate (a derivative of Bromocriptine) is reported as an ingredient of Padoparine in the following countries:


  • Japan

International Drug Name Search

Sunday, November 27, 2011

Lifibrat




Lifibrat may be available in the countries listed below.


Ingredient matches for Lifibrat



Fenofibrate

Fenofibrate is reported as an ingredient of Lifibrat in the following countries:


  • Vietnam

International Drug Name Search

Friday, November 25, 2011

Viadur




In the US, Viadur (leuprolide systemic) is a member of the following drug classes: gonadotropin releasing hormones, hormones/antineoplastics and is used to treat Endometriosis, Hirsutism, Precocious Puberty, Prostate Cancer and Uterine Fibroids.

US matches:

  • Viadur Implant

  • Viadur

Ingredient matches for Viadur



Leuprorelin

Leuprorelin acetate (a derivative of Leuprorelin) is reported as an ingredient of Viadur in the following countries:


  • United States

International Drug Name Search

Monday, November 21, 2011

Rechol




Rechol may be available in the countries listed below.


Ingredient matches for Rechol



Simvastatin

Simvastatin is reported as an ingredient of Rechol in the following countries:


  • Indonesia

International Drug Name Search

Friday, November 18, 2011

Epi-Cell




Epi-Cell may be available in the countries listed below.


Ingredient matches for Epi-Cell



Epirubicin

Epirubicin hydrochloride (a derivative of Epirubicin) is reported as an ingredient of Epi-Cell in the following countries:


  • Austria

  • Denmark

  • Germany

  • Luxembourg

International Drug Name Search

Sunday, November 6, 2011

Insulin B.Braun Comb 30 / 70




Insulin B.Braun Comb 30/70 may be available in the countries listed below.


Ingredient matches for Insulin B.Braun Comb 30/70



Insulin Injection, Biphasic Isophane

Insulin Injection, Biphasic Isophane human (a derivative of Insulin Injection, Biphasic Isophane) is reported as an ingredient of Insulin B.Braun Comb 30/70 in the following countries:


  • Germany

  • Luxembourg

International Drug Name Search

Zentrax




Zentrax may be available in the countries listed below.


Ingredient matches for Zentrax



Albendazole

Albendazole is reported as an ingredient of Zentrax in the following countries:


  • Myanmar

International Drug Name Search

Erythropoietin




ATC (Anatomical Therapeutic Chemical Classification)

B03XA01

CAS registry number (Chemical Abstracts Service)

0011096-26-7

Therapeutic Categories

Antianemic agent

Hematopoietic growth factor

Chemical Name

Glycoprotein hormone which stimulates red blood cell formation in higher organisms

Foreign Names

  • Erythropoietin (German)
  • Erythropoietine (French)
  • Eritropoyetina (Spanish)

Generic Names

  • Ep (IS)
  • Erythropoiesis stimulating factor (IS)
  • ESF (IS)
  • Hemopoietine (IS)
  • r-HuEPO (IS)
  • Erythropoietin Concentrated Solution (PH: BP 2010)

Brand Names

  • Epoglobin
    Ikapharmindo, Indonesia


  • Eporon
    Bioreg, Peru


  • Epotin
    Julphar, Tunisia


  • Epotrex-NP
    Novell, Indonesia


  • Hemax
    Bio Sidus S.A., Vietnam


  • Jimaixin
    NCPC GeneTech, China


  • Pronivel
    Elea, Argentina


  • Retacrit
    Hospira, Ireland

International Drug Name Search

Glossary

ISInofficial Synonym
PHPharmacopoeia Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, November 5, 2011

Histac




Histac may be available in the countries listed below.


Ingredient matches for Histac



Ranitidine

Ranitidine is reported as an ingredient of Histac in the following countries:


  • Oman

  • Peru

  • Thailand

  • Vietnam

Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Histac in the following countries:


  • Bahrain

  • Bulgaria

  • Hungary

  • India

  • Latvia

  • Lithuania

  • Poland

  • Romania

  • Singapore

  • Sri Lanka

International Drug Name Search

Friday, November 4, 2011

Sertralina Ur




Sertralina Ur may be available in the countries listed below.


Ingredient matches for Sertralina Ur



Sertraline

Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Sertralina Ur in the following countries:


  • Spain

International Drug Name Search

Monday, October 31, 2011

Priftin


Priftin is a brand name of rifapentine, approved by the FDA in the following formulation(s):


PRIFTIN (rifapentine - tablet; oral)



  • Manufacturer: SANOFI AVENTIS US

    Approval date: June 22, 1998

    Strength(s): 150MG [RLD]

Has a generic version of Priftin been approved?


No. There is currently no therapeutically equivalent version of Priftin available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Priftin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Priftin.

See also...

  • Priftin Consumer Information (Wolters Kluwer)
  • Priftin Consumer Information (Cerner Multum)
  • Priftin Advanced Consumer Information (Micromedex)
  • Priftin AHFS DI Monographs (ASHP)
  • Rifapentine Consumer Information (Wolters Kluwer)
  • Rifapentine Consumer Information (Cerner Multum)
  • Rifapentine Advanced Consumer Information (Micromedex)
  • Rifapentine AHFS DI Monographs (ASHP)

Thursday, October 20, 2011

Apo-Indap




Apo-Indap may be available in the countries listed below.


Ingredient matches for Apo-Indap



Indapamide

Indapamide is reported as an ingredient of Apo-Indap in the following countries:


  • Poland

International Drug Name Search

Paroxetin-hemihydrat-Teva




Paroxetin-hemihydrat-Teva may be available in the countries listed below.


Ingredient matches for Paroxetin-hemihydrat-Teva



Paroxetine

Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of Paroxetin-hemihydrat-Teva in the following countries:


  • Switzerland

International Drug Name Search

Sunday, October 16, 2011

Oxybutynine EG




Oxybutynine EG may be available in the countries listed below.


Ingredient matches for Oxybutynine EG



Oxybutynin

Oxybutynin hydrochloride (a derivative of Oxybutynin) is reported as an ingredient of Oxybutynine EG in the following countries:


  • France

  • Luxembourg

International Drug Name Search

Saturday, October 15, 2011

Déméclocycline




Déméclocycline may be available in the countries listed below.


Ingredient matches for Déméclocycline



Demeclocycline

Déméclocycline (DCF) is known as Demeclocycline in the US.

International Drug Name Search

Glossary

DCFDénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, October 8, 2011

Oforta


Oforta is a brand name of fludarabine, approved by the FDA in the following formulation(s):


OFORTA (fludarabine phosphate - tablet; oral)



  • Manufacturer: SANOFI AVENTIS US

    Approval date: December 18, 2008

    Strength(s): 10MG [RLD]

Has a generic version of Oforta been approved?


No. There is currently no therapeutically equivalent version of Oforta available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Oforta. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Oral fludara of high-purity formulation with quick release of active ingredient
    Patent 7,148,207
    Issued: December 12, 2006
    Inventor(s): Heil; Wolfgang & Tistam; Ulf & Lipp; Ralph & Tack; Johannes-Wilhelm
    Assignee(s): Schering Aktiengesellschaft
    This invention relates to a quick-release tablet formulation with >99.19% pure fludara (high-purity fludara) as an active ingredient in a defined composition of residual contaminants.
    Patent expiration dates:

    • December 20, 2022
      ✓ 
      Patent use: TREATMENT OF PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
      ✓ 
      Drug product




  • Process for the production of fludarabine-phosphate lithium, sodium, potassium, calcium and magnesium salts and purification process for the production of fludarabine-phosphate and fludarabine-phosphate with a purity of at least 99.5%
    Patent 7,547,776
    Issued: June 16, 2009
    Inventor(s): Tilstam; Ulf & Schmitz; Thomas & Nickisch; Klaus
    Assignee(s): Bayer Schering Pharma Aktiengesellschaft
    The present invention generally relates to a fludarabine-phosphate with a purity of at least 99.5%.
    Patent expiration dates:

    • December 10, 2018
      ✓ 
      Drug substance



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • December 18, 2011 - NEW DOSAGE FORM

    • December 18, 2015 - ORPHAN DRUG EXCLUSIVITY

See also...

  • Oforta Consumer Information (Drugs.com)
  • Oforta Consumer Information (Wolters Kluwer)
  • Oforta Consumer Information (Cerner Multum)
  • Oforta Advanced Consumer Information (Micromedex)
  • Fludarabine Consumer Information (Wolters Kluwer)
  • Fludarabine Tablets Consumer Information (Wolters Kluwer)
  • Fludarabine Consumer Information (Cerner Multum)
  • Fludarabine injection Consumer Information (Cerner Multum)
  • Fludarabine Advanced Consumer Information (Micromedex)
  • Fludarabine Intravenous Advanced Consumer Information (Micromedex)
  • Fludarabine Phosphate AHFS DI Monographs (ASHP)

Thursday, October 6, 2011

Fluconazol Ardez




Fluconazol Ardez may be available in the countries listed below.


Ingredient matches for Fluconazol Ardez



Fluconazole

Fluconazole is reported as an ingredient of Fluconazol Ardez in the following countries:


  • Czech Republic

International Drug Name Search

Monday, October 3, 2011

Flutamida AC Farma




Flutamida AC Farma may be available in the countries listed below.


Ingredient matches for Flutamida AC Farma



Flutamide

Flutamide is reported as an ingredient of Flutamida AC Farma in the following countries:


  • Peru

International Drug Name Search

Monday, September 26, 2011

L-Adrenalin Fresenius




L-Adrenalin Fresenius may be available in the countries listed below.


Ingredient matches for L-Adrenalin Fresenius



Epinephrine

Epinephrine is reported as an ingredient of L-Adrenalin Fresenius in the following countries:


  • Austria

International Drug Name Search

bupivacaine liposome Injection


bue-PIV-a-kane LYE-poh-some


Commonly used brand name(s)

In the U.S.


  • Exparel

Available Dosage Forms:


  • Suspension

Therapeutic Class: Anesthetic, Local


Chemical Class: Amino Amide


Uses For bupivacaine liposome


Bupivacaine liposome injection is used to relieve pain after surgery. It belongs to the family of medicines called local anesthetics. bupivacaine liposome prevents pain by blocking the signals at the nerve endings


bupivacaine liposome is to be given only by or under the direct supervision of a doctor.


Before Using bupivacaine liposome


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For bupivacaine liposome, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to bupivacaine liposome or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of bupivacaine liposome injection in the pediatric population. Safety and efficacy have not been established.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of bupivacaine liposome injection in the elderly. However, elderly patients are more likely to have kidney or liver problems, which may require caution for patients receiving bupivacaine liposome injection.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.


Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of bupivacaine liposome. Make sure you tell your doctor if you have any other medical problems, especially:


  • Bone or joint problems (e.g., chondrolysis)—May increase risk for more serious side effects.

  • Kidney disease or

  • Liver disease—Use with caution. The effects may be increased because of slower removal of the medicine from the body.

  • Obstetrical paracervical block (numbing procedure)—Should not be used in patients having this procedure.

Proper Use of bupivacaine liposome


A nurse or other trained health professional will give you bupivacaine liposome in a hospital. bupivacaine liposome is given through a needle injected into the surgical site (such as big toe).


bupivacaine liposome should cause numbness only to the area where it is injected. You may experience temporary loss of sensation or motor skills to the area injected. This type of numbing procedure is called local anesthesia. It is not meant to cause you to fall asleep or become unconscious.


Bupivacaine liposome injection (Exparel™) works differently with other formulations of bupivacaine, even at the same dose (number of milligrams). Do not convert or change the dosing from any other formulations of bupivacaine to Exparel™.


Precautions While Using bupivacaine liposome


Your doctor will check you closely while you are receiving bupivacaine liposome. This is to check for any problems or unwanted effects that may be caused by bupivacaine liposome.


Tell your doctor or nurse right away if you have the following symptoms after receiving bupivacaine liposome: anxiety, blurred vision, depression, drowsiness, lightheadedness, nausea or vomiting, numbness and tingling of the mouth and lips, restlessness, ringing in the ears, speech problems, or tremors.


bupivacaine liposome may cause serious allergic reactions, including anaphylaxis. Anaphylaxis can be life-threatening and requires immediate medical attention. Call your doctor right away if you have a rash; itching; fever; increased sweating; lightheadedness or fainting; trouble breathing; trouble swallowing; or any swelling of your hands, face, mouth, or throat after receiving bupivacaine liposome.


bupivacaine liposome Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor or nurse immediately if any of the following side effects occur:


More common
  • Bloating or swelling of the face, arms, hands, lower legs, or feet

  • blurred vision

  • confusion

  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position

  • fast, pounding, or irregular heartbeat or pulse

  • fever

  • pale skin

  • rapid weight gain

  • sweating

  • tingling of the hands or feet

  • troubled breathing with exertion

  • unusual bleeding or bruising

  • unusual tiredness or weakness

  • unusual weight gain or loss

Less common
  • Bleeding from the anus

  • burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings

  • chest pain or discomfort

  • fainting

  • lightheadedness, dizziness, or fainting

  • painful defecation

  • shortness of breath

  • slow or irregular heartbeat

  • swelling at the surgical site

Less common or rare
  • Chills

  • decrease in the frequency of urination

  • decrease in the urine volume

  • difficult or troubled breathing

  • difficulty in passing urine (dribbling)

  • extra heart beat

  • headache

  • hives

  • hoarseness

  • irregular, fast or slow, or shallow breathing

  • irritation

  • itching

  • joint pain, stiffness, or swelling

  • nervousness

  • not breathing

  • painful urination

  • pale or blue lips, fingernails, or skin

  • pounding in the ears

  • rash

  • redness of the skin

  • shakiness in the legs, arms, hands, or feet

  • shortness of breath

  • swelling at the incision site

  • tightness in the chest

  • troubled breathing or swallowing

  • weakness

  • wheezing

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Back pain

  • muscle spasm

  • nausea

  • sleepiness or unusual drowsiness

  • sleeplessness

  • trouble sleeping

  • unable to sleep

  • vomiting

Less common
  • Decreased appetite

  • itching in the genital or other skin areas

  • scaling

  • unusual drowsiness, dullness, tiredness, weakness, or feeling of sluggishness

Less common or rare
  • Agitation

  • cold sweats

  • hives or welts

  • increased sweating

  • muscle weakness

  • pain in the neck

  • paleness of the skin

  • restlessness

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

Friday, September 23, 2011

Zegren




Zegren may be available in the countries listed below.


Ingredient matches for Zegren



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Zegren in the following countries:


  • Indonesia

International Drug Name Search

Monday, September 19, 2011

Nevigramon




Nevigramon may be available in the countries listed below.


Ingredient matches for Nevigramon



Nalidixic Acid

Nalidixic Acid is reported as an ingredient of Nevigramon in the following countries:


  • Georgia

  • Hungary

  • Poland

International Drug Name Search

Sunday, September 18, 2011

Canovel Tapewormer




Canovel Tapewormer may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Canovel Tapewormer



Dichlorophen

Dichlorophen is reported as an ingredient of Canovel Tapewormer in the following countries:


  • United Kingdom

International Drug Name Search

Wednesday, September 7, 2011

Moz-Bite




Moz-Bite may be available in the countries listed below.


Ingredient matches for Moz-Bite



Crotamiton

Crotamiton is reported as an ingredient of Moz-Bite in the following countries:


  • Ethiopia

  • Singapore

International Drug Name Search

Saturday, September 3, 2011

Mobalen




Mobalen may be available in the countries listed below.


Ingredient matches for Mobalen



Mexiletine

Mexiletine hydrochloride (a derivative of Mexiletine) is reported as an ingredient of Mobalen in the following countries:


  • Japan

International Drug Name Search

B1-ASmedic




B1-ASmedic may be available in the countries listed below.


Ingredient matches for B1-ASmedic



Thiamine

Thiamine nitrate (a derivative of Thiamine) is reported as an ingredient of B1-ASmedic in the following countries:


  • Germany

International Drug Name Search

Thursday, September 1, 2011

Alkeran




In the US, Alkeran (melphalan systemic) is a member of the drug class alkylating agents and is used to treat Multiple Myeloma and Ovarian Cancer.

US matches:

  • Alkeran

  • Alkeran Tablets

  • Alkeran I.V.

  • Alkeran IV

UK matches:

  • Alkeran Injection 50 mg (SPC)
  • Alkeran Injection Diluent (SPC)

Ingredient matches for Alkeran



Melphalan

Melphalan is reported as an ingredient of Alkeran in the following countries:


  • Australia

  • Austria

  • Bahrain

  • Bangladesh

  • Belgium

  • Brazil

  • Canada

  • Chile

  • Czech Republic

  • Denmark

  • Egypt

  • Estonia

  • Ethiopia

  • Finland

  • Germany

  • Greece

  • Guyana

  • Hong Kong

  • Iceland

  • India

  • Iran

  • Iraq

  • Ireland

  • Israel

  • Italy

  • Japan

  • Jordan

  • Kuwait

  • Latvia

  • Lebanon

  • Lithuania

  • Luxembourg

  • Mexico

  • Netherlands

  • New Zealand

  • Norway

  • Oman

  • Peru

  • Philippines

  • Poland

  • Portugal

  • Qatar

  • Romania

  • Russian Federation

  • Singapore

  • Slovakia

  • Slovenia

  • South Africa

  • Sweden

  • Switzerland

  • Syria

  • Taiwan

  • Thailand

  • Turkey

  • United Arab Emirates

  • United Kingdom

  • United States

  • Yemen

Melphalan hydrochloride (a derivative of Melphalan) is reported as an ingredient of Alkeran in the following countries:


  • Chile

  • Estonia

  • Ireland

  • Italy

  • Lithuania

  • Sweden

  • United Kingdom

  • United States

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, August 27, 2011

Radolin




Radolin may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Radolin



Camphor

Camphor D-Camphor (a derivative of Camphor) is reported as an ingredient of Radolin in the following countries:


  • Switzerland

Levomenthol

Levomenthol is reported as an ingredient of Radolin in the following countries:


  • Switzerland

International Drug Name Search

Thursday, August 25, 2011

Cyproteron NM Pharma




Cyproteron NM Pharma may be available in the countries listed below.


Ingredient matches for Cyproteron NM Pharma



Cyproterone

Cyproterone 17α-acetate (a derivative of Cyproterone) is reported as an ingredient of Cyproteron NM Pharma in the following countries:


  • Iceland

International Drug Name Search

Wednesday, August 24, 2011

Risperidon




Risperidon may be available in the countries listed below.


Ingredient matches for Risperidon



Risperidone

Risperidone is reported as an ingredient of Risperidon in the following countries:


  • Norway

International Drug Name Search

Saturday, August 20, 2011

Ofnifenil




Ofnifenil may be available in the countries listed below.


Ingredient matches for Ofnifenil



Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Ofnifenil in the following countries:


  • Greece

International Drug Name Search

Atenolol PCH




Atenolol PCH may be available in the countries listed below.


Ingredient matches for Atenolol PCH



Atenolol

Atenolol is reported as an ingredient of Atenolol PCH in the following countries:


  • Netherlands

International Drug Name Search

Friday, August 19, 2011

Transient Ischemic Attack Medications


Definition of Transient Ischemic Attack:

A transient ischemic attack (TIA) is an episode in which a person has stroke -like symptoms for up to 1-2 hours. A TIA is often considered a warning sign that a true stroke may happen in the future if something is not done to prevent it.

Drugs associated with Transient Ischemic Attack

The following drugs and medications are in some way related to, or used in the treatment of Transient Ischemic Attack. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Transient Ischemic Attack





Drug List:

Thursday, August 18, 2011

Methotrexat Ebewe




Methotrexat-Ebewe may be available in the countries listed below.


Ingredient matches for Methotrexat-Ebewe



Methotrexate

Methotrexate is reported as an ingredient of Methotrexat-Ebewe in the following countries:


  • Czech Republic

  • Georgia

  • Germany

  • Hungary

  • Indonesia

  • Israel

  • Latvia

  • Lithuania

  • Oman

  • Romania

  • Russian Federation

  • Serbia

  • Slovenia

  • Tunisia

Methotrexate sodium salt (a derivative of Methotrexate) is reported as an ingredient of Methotrexat-Ebewe in the following countries:


  • Poland

  • Slovakia

  • Switzerland

International Drug Name Search

Saturday, August 13, 2011

Vasopressin




In some countries, this medicine may only be approved for veterinary use.


In the US, Vasopressin (vasopressin systemic) is a member of the drug class antidiuretic hormones and is used to treat Abdominal Distension Prior to Abdominal X-ray, Asystole, Diabetes Insipidus, Esophageal Varices with Bleeding and Postoperative Gas Pains.

US matches:

  • Vasopressin

  • Vasopressin Injection

  • Vasopressin (8-Arginine-Vasopressin)

Scheme

USP

ATC (Anatomical Therapeutic Chemical Classification)

H01BA01

CAS registry number (Chemical Abstracts Service)

0000113-79-1

Chemical Formula

C46-H65-N15-O12-S2

Molecular Weight

1084

Therapeutic Category

Posterior pituitary hormone: Antidiuretic hormone, ADH

Chemical Name

Vasopressin

Foreign Names

  • Vasopressini (Latin)
  • Vasopressin (German)
  • Vasopressine (French)
  • Vasopresina (Spanish)

Generic Names

  • Vasopressina (OS: DCIT)
  • Vasopressine (OS: DCF)
  • Antidiuretin (IS)
  • Vasotan (IS)
  • Vasopressin (PH: USP 32)
  • Vasopressin Injection (PH: JP XIV, BP 1980)
  • Vasopressina-Adiuretina preparazione iniettabile (PH: F.U. VIII)
  • Vasopressini injectio (PH: Ph. Int. 2)
  • vasopressini, Iniectabile (PH: Ph. Helv. VI, Editio)

Brand Names

  • App Vasopressin
    APP, Hong Kong


  • Pitressin
    Daiichi Sankyo, Japan; Goldshield, Ireland; JHP, United States; Link, Australia; Link, New Zealand; Pfizer, Taiwan


  • Pitressin (veterinary use)
    Goldshield, United Kingdom


  • Pressyn
    Ferring, Canada


  • Vasopresina U.S.P.
    Comercial Médica, Colombia


  • Vasopresina
    Comercial Médica, Colombia


  • Vasopressin
    American Regent, United States; APP, United States; Pharmaceutical Partners of Canada, Canada; Sandoz, Canada; Watson, United States

International Drug Name Search

Glossary

DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
USPPharmacopoeia of the United States

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, August 12, 2011

Requip XL


Generic Name: ropinirole (Oral route)

roe-PIN-i-role

Commonly used brand name(s)

In the U.S.


  • Requip

  • Requip XL

Available Dosage Forms:


  • Tablet

  • Tablet, Extended Release

Therapeutic Class: Antiparkinsonian


Pharmacologic Class: Dopamine Agonist


Uses For Requip XL


Ropinirole is used alone or with other medicines to treat Parkinson's disease.


It is also used to treat a condition called Restless Legs Syndrome (RLS). RLS is a neurologic disorder that affects sensation and movement in the legs and causes the legs to feel uncomfortable. This results in an overwhelming feeling of wanting to move your legs to make them comfortable.


This medicine is available only with your doctor's prescription.


Before Using Requip XL


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of ropinirole in the pediatric population. Safety and efficacy have not been established.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of ropinirole in the elderly. However, elderly patients are more likely to have age-related liver problems or to develop hallucinations (seeing, hearing, or feeling things that are not there), which may require caution in patients receiving ropinirole.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Warfarin

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Ciprofloxacin

  • Kava

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following may cause an increased risk of certain side effects but may be unavoidable in some cases. If used together, your doctor may change the dose or how often you use this medicine, or give you special instructions about the use of food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Dyskinesia (trouble controlling your muscles) or

  • Hallucinations or

  • Heart or heart rhythm problems or

  • Hypertension (high blood pressure) or

  • Hypotension (low blood pressure) or

  • Mental illness or

  • Postural hypotension (dizziness, lightheadedness, or fainting when getting up from a lying or sitting position)—Ropinirole may make these conditions worse.

  • Kidney problems—May increase chance of side effects.

  • Liver problems—Higher blood levels of ropinirole may result, and cause an increase in side effects.

  • Lung problems resulting from treatment with some other Parkinson's disease medicines—Ropinirole may cause the condition to recur.

  • Sleep disorders or

  • Sleepiness, history of in the past—May cause side effects to be worse.

Proper Use of ropinirole

This section provides information on the proper use of a number of products that contain ropinirole. It may not be specific to Requip XL. Please read with care.


Take this medicine every day exactly as ordered by your doctor in order to improve your condition as much as possible. Do not take more of it or less of it, and do not take it more or less often than your doctor ordered.


Read the Patient Information leaflet before you take this medicine and each time you get your prescription refilled.


This medicine may be taken with or without food, or on an empty or full stomach. Taking this medicine with food may reduce nausea.


Swallow the extended-release tablets whole. Do not split, crush, or chew it.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage form (extended-release tablets):
    • For Parkinson's disease:
      • Adults—At first, 2 milligrams (mg) once a day for 1 to 2 weeks. Your doctor may increase your dose as needed and tolerated. However, the dose is usually not more than 24 mg per day.

      • Children—Use and dose must be determined by your doctor.



  • For oral dosage form (tablets):
    • For Parkinson's disease:
      • Adults—At first, 0.25 milligrams (mg) three times a day. Your doctor will increase your dose as needed and tolerated. However, the dose is usually not more than 24 mg a day.

      • Children—Use and dose must be determined by your doctor.


    • For Restless Legs Syndrome:
      • Adults—At first, 0.25 mg once a day, 1 to 3 hours before bedtime. Your doctor will increase your dose as needed and tolerated. However, the dose is usually not more than 4 mg a day.

      • Children—Use and dose must be determined by your doctor.



Missed Dose


If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Precautions While Using Requip XL


It is important that your doctor check your progress at regular visits to allow changes in your dose and to check for any unwanted effects.


Do not stop taking this medicine without first checking with your doctor. Your doctor may want you to reduce gradually the amount you are taking before stopping completely.


People taking ropinirole have reported falling asleep without warning during activities of daily living, including driving, which sometimes resulted in accidents. This may happen as late as one year after taking the medicine. Therefore, make sure you know how you react to this medicine before you drive, use machines, or do anything else that could be dangerous if you are not alert, well-coordinated, or able to think or see well.


This medicine will add to the effects of alcohol and other CNS depressants (medicines that slow down the nervous system, possibly causing drowsiness). Some examples of CNS depressants are antihistamines or medicine for hay fever, other allergies, or colds; sedatives, tranquilizers, or sleeping medicine; prescription pain medicine or narcotics; barbiturates; medicine for seizures; muscle relaxants; or anesthetics, including some dental anesthetics. Check with your doctor before taking any of the above while you are using this medicine.


Dizziness, lightheadedness, or fainting may occur, especially when you get up from a lying or sitting position. These symptoms are more likely to occur when you begin taking this medicine, or when the dose is increased. Getting up slowly may help. If you should have this problem, check with your doctor.


Hallucinations may occur in some patients. This is more common with elderly patients. If you have hallucinations, check with your doctor.


Since smoking may decrease the treatment effects of this medicine, it is best to avoid smoking while you are using it. If you have any questions about this, check with your doctor.


It is important that your doctor check your skin for melanoma regularly if you have Parkinson's disease. .


Some people who have used this medicine had unusual changes in their behavior. Talk with your doctor if you start having problems with gambling or increased sex drive while using this medicine.


Requip XL Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Confusion

  • dizziness, faintness, or lightheadedness when getting up from a lying or sitting position suddenly

  • drowsiness

  • falling

  • nausea

  • seeing, hearing, or feeling things that are not there (hallucinations)

  • sleepiness or unusual drowsiness

  • swelling of legs

  • twisting, twitching, or other unusual body movements

  • unusual tiredness or weakness

  • worsening of parkinsonism

Less common
  • Abdominal pain

  • bloating or swelling of the face, arms, hands, lower legs, or feet

  • blood in urine

  • blurred vision

  • burning, pain, or difficulty in urinating

  • chest pain

  • chills

  • cold sweats

  • cough

  • double vision or other eye or vision problems

  • fainting

  • fear or nervousness

  • feeling of constant movement of self or surroundings

  • high or low blood pressure

  • irregular or pounding heartbeat

  • loss of memory

  • mental depression

  • pain

  • pain in arms or legs

  • pounding in the ears

  • rapid weight gain

  • sensation of spinning

  • shortness of breath

  • slow or fast heartbeat

  • sore throat

  • sweating

  • tightness in chest

  • tingling of hands or feet

  • tingling, numbness, or prickly feelings

  • trouble in concentrating

  • troubled breathing

  • unusual weight gain or loss

  • vomiting

  • wheezing

Rare
  • Anxiety

  • buzzing or ringing in the ears

  • changes in vision

  • fever

  • headache

  • joint pain

  • loss of bladder control

  • muscle cramps, pain, or spasms

  • nasal congestion

  • runny nose

  • sneezing

  • trouble in swallowing

  • unusual urges

Get emergency help immediately if any of the following symptoms of overdose occur:


Symptoms of overdose
  • Agitation

  • fatigue

  • grogginess

  • increase in unusual body movements, especially of the face or mouth

  • increased coughing

  • increased sweating

  • lack or loss of strength

  • nightmares

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


Less common
  • Abnormal dreams

  • acid or sour stomach

  • back pain

  • belching

  • decrease in sexual desire or performance

  • difficulty having a bowel movement (stool)

  • dryness of mouth

  • flushing

  • general feeling of discomfort or illness

  • heartburn or gas

  • hot flashes

  • indigestion

  • loss of appetite

  • tremor

  • weight loss

  • yawning

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Requip XL side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Requip XL resources


  • Requip XL Side Effects (in more detail)
  • Requip XL Use in Pregnancy & Breastfeeding
  • Drug Images
  • Requip XL Drug Interactions
  • Requip XL Support Group
  • 3 Reviews for Requip XL - Add your own review/rating


  • Requip XL Extended-Release Tablets MedFacts Consumer Leaflet (Wolters Kluwer)

  • Requip Prescribing Information (FDA)

  • Requip MedFacts Consumer Leaflet (Wolters Kluwer)

  • Requip Monograph (AHFS DI)

  • Requip Consumer Overview

  • Ropinirole Prescribing Information (FDA)



Compare Requip XL with other medications


  • Parkinson's Disease
  • Periodic Limb Movement Disorder

Friday, August 5, 2011

Nexe




Nexe may be available in the countries listed below.


Ingredient matches for Nexe



Esomeprazole

Esomeprazole is reported as an ingredient of Nexe in the following countries:


  • Bangladesh

International Drug Name Search

Wednesday, August 3, 2011

Azibiot




Azibiot may be available in the countries listed below.


Ingredient matches for Azibiot



Azithromycin

Azithromycin is reported as an ingredient of Azibiot in the following countries:


  • Bulgaria

  • Croatia (Hrvatska)

Azithromycin dihydrate (a derivative of Azithromycin) is reported as an ingredient of Azibiot in the following countries:


  • Mexico

  • Poland

  • Slovenia

International Drug Name Search

Saturday, July 16, 2011

Travilan




Travilan may be available in the countries listed below.


Ingredient matches for Travilan



Ceftriaxone

Ceftriaxone disodium salt (a derivative of Ceftriaxone) is reported as an ingredient of Travilan in the following countries:


  • Greece

  • Malta

International Drug Name Search

Tuesday, July 12, 2011

L-CCL




L-CCL may be available in the countries listed below.


Ingredient matches for L-CCL



Cefaclor

Cefaclor is reported as an ingredient of L-CCL in the following countries:


  • Japan

International Drug Name Search

Monday, July 11, 2011

Or-Phen-Ade


Generic Name: chlorpheniramine and phenylpropanolamine (klor feh NEER a meen and feh nill proe pa NO la meen)

Brand Names: A.R.M. Allergy Relief, Allerest 12 Hour, Chlornade, Condrin, Contac 12 Hour, Decongex-3, Demazin, Dura-Vent/A, Equi-Nade, Genamin, Gencold, Histade, Or-Phen-Ade, Ordrine, Ornade Spansules, Resaid, Rescon Liquid, Rhinolar-EX, Teldrin, Triac, Triaminic, Vanex Forte-R


What is Or-Phen-Ade (chlorpheniramine and phenylpropanolamine)?

Chlorpheniramine is an antihistamine. It blocks the effects of the naturally occurring chemical histamine in the body. Chlorpheniramine prevents sneezing; itchy, watery eyes and nose; and other symptoms of allergies and hay fever.


Phenylpropanolamine is a decongestant. It constricts (shrinks) blood vessels (veins and arteries). This reduces the blood flow to certain areas and allows nasal passages to open up.


Chlorpheniramine and phenylpropanolamine is used to treat nasal congestion and sinusitis (inflammation of the sinuses) associated with allergies, hay fever, and the common cold.


Phenylpropanolamine, an ingredient in this product, has been associated with an increased risk of hemorrhagic stroke (bleeding into the brain or into tissue surrounding the brain) in women. Men may also be at risk. Although the risk of hemorrhagic stroke is low, the U.S. Food and Drug Administration (FDA) recommends that consumers not use any products that contain phenylpropanolamine.


Chlorpheniramine and phenylpropanolamine may also be used for purposes other than those listed in this medication guide.


What is the most important information I should know about Or-Phen-Ade (chlorpheniramine and phenylpropanolamine)?


Phenylpropanolamine, an ingredient in this product, has been associated with an increased risk of hemorrhagic stroke (bleeding into the brain or into tissue surrounding the brain) in women. Men may also be at risk. Although the risk of hemorrhagic stroke is low, the U.S. Food and Drug Administration (FDA) recommends that consumers not use any products that contain phenylpropanolamine.


Use caution when driving, operating machinery, or performing other hazardous activities. Chlorpheniramine and phenylpropanolamine may cause dizziness or drowsiness. If you experience dizziness or drowsiness, avoid these activities. Use alcohol cautiously. Alcohol may increase drowsiness and dizziness while taking chlorpheniramine and phenylpropanolamine.

Do not take more of this medication than is recommended. If your symptoms do not improve, or if they worsen, talk to your doctor.


Who should not take Or-Phen-Ade (chlorpheniramine and phenylpropanolamine)?


Do not take chlorpheniramine and phenylpropanolamine if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

Before taking this medication, tell your doctor if you have


  • kidney disease,

  • liver disease,


  • diabetes,




  • glaucoma,




  • any type of heart disease or high blood pressure,




  • thyroid disease,




  • emphysema or chronic bronchitis, or




  • difficulty urinating or an enlarged prostate.



You may not be able to take chlorpheniramine and phenylpropanolamine, or you may require a dosage adjustment or special monitoring during treatment if you have any of the conditions listed above.


Chlorpheniramine and phenylpropanolamine is in the FDA pregnancy category B. This means that it is unlikely to harm an unborn baby. Do not take this medication without first talking to your doctor if you are pregnant. This medication passes into breast milk and may harm a nursing baby. Do not take this medication without first talking to your doctor if you are breast-feeding a baby. If you are over 65 years of age, you may be more likely to experience side effects from chlorpheniramine and phenylpropanolamine. You may require a lower dose of this medication. Read the package label for directions or consult your doctor or pharmacist before treating a child with this medication. Children are more susceptible than adults to the effects of medicines and may have unusual reactions.

How should I take Or-Phen-Ade (chlorpheniramine and phenylpropanolamine)?


Take chlorpheniramine and phenylpropanolamine exactly as directed. If you do not understand these directions, ask your pharmacist, nurse, or doctor to explain them to you.


Take each dose with a full glass of water. Do not crush, chew, or break the long-acting or sustained-release forms of this medication. Swallow them whole. If you are unsure of the formulation of your medicine, ask your pharmacist for help.

If you cannot swallow the tablets or capsules, look for a liquid form of the medication.


To ensure that you get a correct dose, measure the liquid forms of chlorpheniramine and phenylpropanolamine with a special dose-measuring spoon or cup, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist where you can get one.


Do not take more of this medication than is recommended. An overdose of this medication can cause serious harm.

Do not take chlorpheniramine and phenylpropanolamine for longer than 7 days in a row. If your symptoms do not improve, if they get worse, or if you have a fever, talk to your doctor.


Store chlorpheniramine and phenylpropanolamine at room temperature away from moisture and heat.

What happens if I miss a dose?


Take the missed dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and take only the next regularly scheduled dose. Do not take a double dose of this medication.


What happens if I overdose?


Seek emergency medical attention.

Symptoms of a chlorpheniramine and phenylpropanolamine overdose include a dry mouth, large pupils, flushing, nausea, and vomiting.


What should I avoid while taking Or-Phen-Ade (chlorpheniramine and phenylpropanolamine)?


Use caution when driving, operating machinery, or performing other hazardous activities. Chlorpheniramine and phenylpropanolamine may cause dizziness or drowsiness. If you experience dizziness or drowsiness, avoid these activities. Use alcohol cautiously. Alcohol may increase drowsiness and dizziness while taking chlorpheniramine and phenylpropanolamine.

Chlorpheniramine and phenylpropanolamine may increase the effects of other drugs that cause drowsiness, including antidepressants, alcohol, other antihistamines, pain relievers, anxiety medicines, seizure medicines, and muscle relaxants. Dangerous sedation, dizziness, or drowsiness may occur if chlorpheniramine and phenylpropanolamine is taken with any of these medications.


Or-Phen-Ade (chlorpheniramine and phenylpropanolamine) side effects


Serious side effects are unlikely to occur. Stop taking chlorpheniramine and phenylpropanolamine and seek emergency medical attention if you experience an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives).

Other, less serious side effects may be more likely to occur. Continue to take chlorpheniramine and phenylpropanolamine and talk to your doctor or try another similar medication if you experience



  • dryness of the eyes, nose, and mouth;




  • drowsiness or dizziness;




  • blurred vision;




  • difficulty urinating; or




  • excitation in children.



Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome.


What other drugs will affect Or-Phen-Ade (chlorpheniramine and phenylpropanolamine)?


Do not take chlorpheniramine and phenylpropanolamine if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

Do not take other over-the-counter cough, cold, allergy, diet, or sleep aids while taking chlorpheniramine and phenylpropanolamine without first talking to your doctor or pharmacist. Other medications may also contain chlorpheniramine, phenylpropanolamine, or other similar drugs. You may accidentally take too much of these medicines.


Chlorpheniramine and phenylpropanolamine may increase the effects of other drugs that cause drowsiness, including antidepressants, alcohol, other antihistamines, pain relievers, anxiety medicines, seizure medicines, and muscle relaxants. Dangerous sedation, dizziness, or drowsiness may occur if chlorpheniramine and phenylpropanolamine is taken with any of these medications.


Drugs other than those listed here may also interact with chlorpheniramine and phenylpropanolamine. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines.



More Or-Phen-Ade resources


  • Or-Phen-Ade Drug Interactions
  • Or-Phen-Ade Support Group
  • 0 Reviews for Or-Phen-Ade - Add your own review/rating


  • Triaminic Consumer Overview



Compare Or-Phen-Ade with other medications


  • Cold Symptoms
  • Cough and Nasal Congestion
  • Hay Fever
  • Sinusitis
  • Upper Respiratory Tract Infection


Where can I get more information?


  • Your pharmacist has additional information about chlorpheniramine and phenylpropanolamine written for health professionals that you may read.

What does my medication look like?


Many formulations of chlorpheniramine and phenylpropanolamine are available both over-the-counter and with a prescription. Ask your pharmacist any questions you have about this medication, especially if it is new to you.